Description
A modern approach to diurnal IOP monitoring
The iCare HOME2 tonometer for patient use revolutionizes glaucoma care. The patient can take IOP measurements during normal daily activities throughout the day and the iCare HOME2 can even be used when the patient is lying down. Measurement results are uploaded to a cloud database from where they are easily accessible both to the doctor and the patient. The doctor is provided with accurate real world IOP data to support treatment decisions.
Enhanced ease of use with iCare HOME2 and PATIENT2
The iCare HOME2 monitoring is easy to deploy as most patients can use the device with the help of intuitive training materials. iCare HOME2 guides the patient to take high quality measurements every time. As with all iCare tonometers, measuring requires no anesthesia, drops, air or other preparation. Many clinical studies have shown iCare HOME, the predecessor of iCare HOME2, to be accurate and reliable.
With the intuitive PATIENT2 mobile app, the patient can follow his or her IOP trends in an iOS or Android mobile device and easily send the IOP results for healthcare professional’s review.
Glaucoma treatment decisions supported by comprehensive and reliable IOP data
iCare HOME2 allows measurements at different times of the day over several days providing a comprehensive picture of intraocular pressure fluctuations. At-home measurements may help reveal IOP spikes that would not have been identified had measurements only been taken during office hours, in the clinic. Doctors have access to the IOP results at any time and the system can be configured to send the doctor an e-mail alert if the IOP rises above a pre-set limit.
Benefits of using iCare HOME2
- iCare HOME2 helps to compare the effect of various medications on IOP to find the optimum regime for a specific patient.
- The IOP data can reveal the need for surgery sooner. iCare’s gentle measurement technique allows post-surgical monitoring to begin without delay.
- iCare HOME2 can be instrumental when treating patients with progressing glaucoma despite reasonable IOPs at the clinic.
- iCare HOME2 can be invaluable during these pandemic times, enabling patients to collect IOP data and clinicians to follow up with them remotely.
- The ability to deliver virtual care is valuable in rural and remote settings.
